Kashin-Beck disease in Sichuan, China: Report of a pilot open therapeutic trial

Journal of Clinical Rheumatology

Volumn 18, Issue 1, 2012, Pages 8-14

  Liu, Wei ^a   Liu, Gang ^a,b   Pei, Fuxing ^b   Liu, Yixin ^a   Zhou, Zongke ^b   Li, Jian ^b   Shen, Bin ^b   Kang, Pengde ^b   Xie, Qibing ^a   Ma, Xin ^a  

^a SICHUAN UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

Author keywords

diclofenac sodium; glucosamine hydrochloride; Kashin Beck disease; naproxen

Indexed keywords

DICLOFENAC; GLUCOSAMINE; NAPROXEN;

ADULT; AGED; ANALGESIA; ARTICLE; CHINA; DAILY LIFE ACTIVITY; DRUG EFFICACY; DRUG SAFETY; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEART MUSCLE INJURY; HUMAN; KASHIN BECK DISEASE; MAJOR CLINICAL STUDY; MALE; OPEN STUDY; PAIN ASSESSMENT; PHYSICIAN; PRIORITY JOURNAL; SELF CARE; TREATMENT DURATION; VISUAL ANALOG SCALE;

ADULT; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CHINA; DICLOFENAC; FEMALE; GLUCOSAMINE; HUMANS; KASHIN-BECK DISEASE; MALE; MIDDLE AGED; NAPROXEN; PAIN MEASUREMENT; PILOT PROJECTS; SELF CARE; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 84855186575     PISSN: 10761608     EISSN: 15367355     Source Type: Journal    
DOI: 10.1097/RHU.0b013e31823e3a3b     Document Type: Article

References (13)

1. Zhai SS, Kimbrough RD, Meng B, et al. Kashin-Beck disease: A cross-sectional study in seven villages in the People's Republic of China. J Toxicol Environ Health. 1990;30:239-259. (Pubitemid 20269909)
2. Wang Y, Yang Z, Gilula LA, et al. Kashin-Beck disease: Radiographic appearance in the hands and wrists. Radiology. 1996;201:265-270. (Pubitemid 26314400)
3. Moerman J, Uyttendaele D, Van den Broecke W, et al. Kashin-Beck's disease. Acta Orthop Belg. 1992;58:227-230.
4. Hinsenkamp M, Mathieu F, Claus W, et al. Effects of physical environment on the evolution of Kashin-Beck disease in Tibet. Int Orthop. 2009;33:1085-1088.
5. Mathieu F, Begaux F, Lan ZY, et al. Clinical manifestations of Kashin-Beck disease in Nyemo Valley, Tibet. Int Orthop. 1997;21:151-156. (Pubitemid 27371114)
6. Bellamy N, Buchanan WW, Goldsmith CH, et al. Validation study of WOMAC: A health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol. 1988;15:1833-1840. (Pubitemid 19037656)
7. Alegre Marcet C, Barcelo Torrent P, Casademont Vilaseca M, et al. Double-blind multicentric, comparative between-patient trial of diclofenac and indomethacin, in arthritis treated during 3 months. Clinical and biological evaluation and statistic analysis of the results [in Spanish]. Rev Esp Reum Enferm Osteoartic. 1977;20:139-157. (Pubitemid 8118238)
8. Yildizhan R, Yildizhan B, Sahin S, et al. Comparison of the efficacy of diclofenac and indomethacin suppositories in treating perineal pain after episiotomy or laceration: A prospective, randomized, double-blind clinical trial. Arch Gynecol Obstet. 2009;280: 735-738.
9. Brogden RN, Heel RC, Pakes GE, et al. Diclofenac sodium: A review of its pharmacological properties and therapeutic use in rheumatic diseases and pain of varying origin. Drugs. 1980;20:24-48. (Pubitemid 11245967)
10. Bozkurt N, Kurdoglu M, Kurdoglu Z, et al. Postoperative pain control after cesarean section: Can diclofenac sodium be used instead of meperidine? J Matern Fetal Neonatal Med. 2009;22: 1144-1150.
11. Derry P, Derry S, Moore RA, et al. Single dose oral diclofenac for acute postoperative pain in adults. Cochrane Database Syst Rev. 2009;CD004768.
12. Lee YH, Woo JH, Choi SJ, et al. Effect of glucosamine or chondroitin sulfate on the osteoarthritis progression: A meta-analysis. Rheumatol Int. 2010;30:357-363.
13. Reginster JY, Deroisy R, Rovati LC, et al. Long-term effects of glucosamine sulphate on osteoarthritis progression: A randomised, placebo-controlled clinical trial. Lancet. 2001;357:251-256. (Pubitemid 32120855)